Talon Private Wealth LLC Takes $3.22 Million Position in Tenet Healthcare Corporation $THC

Talon Private Wealth LLC purchased a new stake in shares of Tenet Healthcare Corporation (NYSE:THC) during the 1st quarter, Holdings Channel reports. The fund purchased 17,053 shares of the company’s stock, valued at approximately $3,218,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Norges Bank acquired a new position in Tenet Healthcare during the 4th quarter valued at about $248,494,000. Wellington Management Group LLP grew its holdings in Tenet Healthcare by 1,114.2% during the 4th quarter. Wellington Management Group LLP now owns 1,135,801 shares of the company’s stock worth $225,706,000 after acquiring an additional 1,042,260 shares during the period. Boston Partners increased its holdings in Tenet Healthcare by 38.8% in the third quarter. Boston Partners now owns 3,147,555 shares of the company’s stock valued at $638,958,000 after purchasing an additional 880,413 shares during the last quarter. AQR Capital Management LLC raised its position in shares of Tenet Healthcare by 62.3% in the 3rd quarter. AQR Capital Management LLC now owns 1,876,423 shares of the company’s stock valued at $380,989,000 after acquiring an additional 720,160 shares during the period. Finally, Alliancebernstein L.P. raised its stake in Tenet Healthcare by 375.7% during the 2nd quarter. Alliancebernstein L.P. now owns 790,254 shares of the company’s stock worth $139,085,000 after buying an additional 624,125 shares during the period. 95.44% of the stock is owned by institutional investors.

Insider Activity at Tenet Healthcare

In other Tenet Healthcare news, Director Christopher S. Lynch sold 3,837 shares of the business’s stock in a transaction on Monday, July 27th. The shares were sold at an average price of $243.44, for a total transaction of $934,079.28. Following the completion of the sale, the director owned 9,568 shares in the company, valued at approximately $2,329,233.92. The trade was a 28.62% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, EVP Paola M. Arbour sold 10,878 shares of the company’s stock in a transaction dated Monday, July 27th. The stock was sold at an average price of $243.90, for a total transaction of $2,653,144.20. Following the completion of the sale, the executive vice president owned 18,413 shares in the company, valued at $4,490,930.70. This represents a 37.14% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 23,353 shares of company stock valued at $5,103,217. 0.97% of the stock is currently owned by company insiders.

Tenet Healthcare News Summary

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Strong Q2 results and improved outlook: Tenet beat analyst expectations for both earnings and revenue, while raising its 2026 forecast. Performance was driven by solid same-facility growth and disciplined expense management, reinforcing the company’s operating momentum. Tenet Healthcare Tops Q2 Earnings Estimates, Raises 2026 Outlook
• Positive Sentiment: Analysts raise price targets: Truist increased its target to $290 from $270 and maintained a “buy” rating. Guggenheim raised its target to $283 from $242 and also rated the shares “buy.” The upgrades suggest analysts see further upside following the earnings beat and improved guidance. Analyst price-target updates
• Positive Sentiment: Growth-stock appeal: Zacks highlighted Tenet as a highly ranked growth stock, which could attract additional interest from growth, value and momentum-focused investors. Tenet Healthcare Is a Top-Ranked Growth Stock
• Neutral Sentiment: Mixed analyst signal: Robert W. Baird lifted its target sharply to $280 from $210 but retained a “neutral” rating, indicating improved valuation expectations without a full shift to a bullish stance. Analyst price-target update
• Negative Sentiment: Executive and director stock sales: EVP Paola M. Arbour sold 10,878 shares worth approximately $2.65 million, reducing her position by 37.14%. Director Christopher S. Lynch sold 3,837 shares worth about $934,000, cutting his ownership by 28.62%. Although these sales may be for personal or tax-related reasons, the sizable transactions could create a modest overhang for THC. Tenet Healthcare insider transaction filing

Analyst Upgrades and Downgrades

THC has been the topic of several research reports. Stephens reaffirmed an “overweight” rating and issued a $285.00 price objective on shares of Tenet Healthcare in a research report on Monday. Guggenheim boosted their target price on shares of Tenet Healthcare from $242.00 to $283.00 and gave the stock a “buy” rating in a report on Tuesday. The Goldman Sachs Group restated a “buy” rating and issued a $305.00 price target on shares of Tenet Healthcare in a research note on Tuesday. Piper Sandler set a $308.00 price target on Tenet Healthcare in a report on Monday. Finally, Royal Bank Of Canada lifted their price target on shares of Tenet Healthcare from $236.00 to $283.00 and gave the company an “outperform” rating in a research report on Monday. Seventeen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $268.50.

Tenet Healthcare Stock Up 7.8%

Shares of NYSE THC opened at $262.36 on Wednesday. The company’s 50 day moving average price is $187.59 and its 200-day moving average price is $198.22. The company has a debt-to-equity ratio of 2.00, a quick ratio of 1.35 and a current ratio of 1.41. Tenet Healthcare Corporation has a 52-week low of $155.02 and a 52-week high of $262.68. The company has a market capitalization of $22.60 billion, a P/E ratio of 10.12, a price-to-earnings-growth ratio of 1.37 and a beta of 1.27.

Tenet Healthcare (NYSE:THC) last announced its earnings results on Friday, July 24th. The company reported $6.12 earnings per share for the quarter, topping analysts’ consensus estimates of $4.26 by $1.86. Tenet Healthcare had a net margin of 10.27% and a return on equity of 26.76%. The business had revenue of $6.04 billion during the quarter, compared to the consensus estimate of $5.43 billion. During the same quarter last year, the firm earned $4.02 earnings per share. Tenet Healthcare’s quarterly revenue was up 6.8% on a year-over-year basis. Equities analysts forecast that Tenet Healthcare Corporation will post 20.9 earnings per share for the current year.

Tenet Healthcare Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.